Healthcare, biotechnology & medical AI Product
SmartChest flags two suspected findings for chest X-ray triage
Milvue’s SmartChest analyzes frontal chest X-rays for signs of suspected pneumothorax or pleural effusion and notifies readers when a study may warrant prioritization. [1]
- Release status
- U.S. FDA 510(k) clearance K232410, decided May 10, 2024. [1]
What it does
The FDA cleared SmartChest under 510(k) K232410 on May 10, 2024, as radiological triage and notification software. [1]
Why it matters
The software affects how a study is flagged in a reading workflow. Its regulatory record covers a defined triage task for two possible findings. [1]
Who it’s for
The labeled setting involves qualified imaging readers handling frontal chest radiographs. [1]
Key dates
- FDA clears SmartChest [1]
Where it fits
The device analyzes the image in the background and sends a notification to support worklist prioritization. [1]
Limits and trade-offs
The filing describes a triage aid for the identified findings and image views. The result does not constitute a report or an independent diagnosis. [1]
Sources and verification
Catalog evidence checked How we verify records
- Primary source FDA 510(k) decision for SmartChest (K232410)
Related profiles
Healthcare, biotechnology & medical AI
Sleep Analysis Module (SAM)
Neurotronics (Nihon Kohden)
The module estimates sleep time from a signal captured during its intended sleep-testing workflow.
Healthcare, biotechnology & medical AI
Heartvue.Proton
Heartvue.ai
It is software for analyzing cardiac MRI images within its documented intended-use scope.
Healthcare, biotechnology & medical AI
ThinkSono Guidance
ThinkSono
Provides guidance during acquisition of lower-extremity compression ultrasound images for review by healthcare professionals.